Buchumschlag

Structure‐based design of antibodies targeting the EBNA1 DNA‐binding domain to block Epstein–Barr virus latent infection and tumor growth

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Yongyue Han, Fang Wu, Ying Zhang, Jun Liu, Yuzhe Wu, Yuecheng Wang, Xiwen Jiang, Xin Chen, Wei Xu
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2024
Schlagworte:	MedComm
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Detection of Epstein‒Barr virus DNA methylation as tumor markers of nasopharyngeal carcinoma patients in saliva, oropharyngeal swab, oral swab, and mouthwash
von: Xiao‐Hui Zheng, et al.
Veröffentlicht: (2024)

Recombinant protein HR212 targeting heptad repeat 2 domain in spike protein S2 subunit elicits broad‐spectrum neutralizing antibodies against SARS‐CoV‐2 and its variants
von: Ying Lu, et al.
Veröffentlicht: (2025)

Hepatocellular carcinoma: signaling pathways, targeted therapy, and immunotherapy
von: Xiaoting Luo, et al.
Veröffentlicht: (2024)

Epidermal growth factor receptor‑targeted antibody nimotuzumab combined with chemoradiotherapy improves survival in patients with locally advanced head and neck squamous cell carcinoma: a propensity score matching real‐world study
von: Peng Zhang, et al.
Veröffentlicht: (2024)

Hypoxia‐activated ADCC‐enhanced humanized anti‐CD147 antibody for liver cancer imaging and targeted therapy with improved selectivity
von: Fang‐Zheng Qi, et al.
Veröffentlicht: (2024)

SMARCAL1: a new target for taming tumor immune evasion
von: Ting Xiao, et al.
Veröffentlicht: (2024)

Airway epithelial‐derived exosomes induce acute asthma exacerbation after respiratory syncytial virus infection
von: Ye Yao, et al.
Veröffentlicht: (2024)

Butyrolactone I blocks the transition of acute kidney injury to chronic kidney disease in mice by targeting JAK1
von: Zijun Zhang, et al.
Veröffentlicht: (2025)

Redefining DNA cleavage in type I CRISPR systems with the HNH domain
von: Senfeng Zhang, et al.
Veröffentlicht: (2025)

Cell death pathways: molecular mechanisms and therapeutic targets for cancer
von: Shaohui Wang, et al.
Veröffentlicht: (2024)

The Epstein–Barr Virus Envelope Glycoprotein BALF4 Promotes the Ubiquitination and Degradation of RNA Acetyltransferase NAT10 Suppressing Gastric Cancer Progression
von: Tianle Qiu, et al.
Veröffentlicht: (2025)

Renal cancer: signaling pathways and advances in targeted therapies
von: Aimin Jiang, et al.
Veröffentlicht: (2024)

Multiorgan proteomic analysis of infected animal models predict potential host factors for chikungunya virus
von: Dongdong Lin, et al.
Veröffentlicht: (2025)

Chronic hepatitis B virus infection deteriorates disease outcome of coronavirus disease 2019 in hamster
von: Lunzhi Yuan, et al.
Veröffentlicht: (2024)

The rising roles of exosomes in the tumor microenvironment reprogramming and cancer immunotherapy
von: Yu Wu, et al.
Veröffentlicht: (2024)

Regulation of bone homeostasis: signaling pathways and therapeutic targets
von: Zebin Wu, et al.
Veröffentlicht: (2024)

CREB3 suppresses hepatocellular carcinoma progression by depressing AKT signaling through competitively binding with insulin receptor and transcriptionally activating RNA‐binding motif protein 38
von: Yi He, et al.
Veröffentlicht: (2024)

Little ones can do big things: Small molecule inhibitors target PTPN2/PTPN1 for tumor immunotherapy
von: Junyu Wang, et al.
Veröffentlicht: (2024)

Protein posttranslational modifications in metabolic diseases: basic concepts and targeted therapies
von: Yunuo Yang, et al.
Veröffentlicht: (2024)

Tumor‐associated exosomes in cancer progression and therapeutic targets
von: Xiaomin Liu, et al.
Veröffentlicht: (2024)

Circulating tumor DNA analysis for prediction of prognosis and molecular insights in patients with resectable gastric cancer: results from a prospective study
von: Zheng Liu, et al.
Veröffentlicht: (2025)

Ultrahigh Dose Rate Irradiation Regulates Mitochondrial DNA‐induced Interferon‐β Secretion via Cytochrome c Leakage
von: Jianfeng Lv, et al.
Veröffentlicht: (2025)

The multifaceted functions of DNA‐PKcs: implications for the therapy of human diseases
von: Jinghong Wu, et al.
Veröffentlicht: (2024)

Remodeling tumor‐associated macrophage for anti‐cancer effects by rational design of irreversible inhibition of mitogen‐activated protein kinase‐activated protein kinase 2
von: Danyi Wang, et al.
Veröffentlicht: (2024)

Development of a SARS‐CoV‐2 neutralization assay based on a pseudotyped virus using a HIV system
von: Ziteng Liang, et al.
Veröffentlicht: (2024)

Therapeutic targeting of white adipose tissue metabolic dysfunction in obesity: mechanisms and opportunities
von: Zi‐Han Yang, et al.
Veröffentlicht: (2024)

Ferroptosis: mechanisms and therapeutic targets
von: Qian Zhou, et al.
Veröffentlicht: (2024)

Phase 1b trial of anti‐HER2 antibody inetetamab and pan‐HER inhibitor pyrotinib in HER2‐positive advanced lung cancer
von: Yihua Huang, et al.
Veröffentlicht: (2024)

Structural insight into interleukin‐4Rα and interleukin‐5 inhibition by nanobodies from a bispecific antibody
von: Weicheng Qiu, et al.
Veröffentlicht: (2024)

Chemoproteomics enables identification of coatomer subunit zeta‐1 targeted by a small molecule for enterovirus A71 inhibition
von: Xiaoyong Li, et al.
Veröffentlicht: (2024)

Inducing disulfidptosis in tumors:potential pathways and significance
von: Tao Mi, et al.
Veröffentlicht: (2024)

Penfluridol inhibits melanoma growth and metastasis through enhancing von Hippel‒Lindau tumor suppressor‐mediated cancerous inhibitor of protein phosphatase 2A (CIP2A) degradation
von: Fuyan Xu, et al.
Veröffentlicht: (2024)

The Systematic Comparison of Enhancer of Zeste Homolog‐2‐, Bromodomain‐containing Proteins‐, Histone Deacetylase‐, and DNA‐methyltransferase 1‐inhibitors in a Syngeneic Murine Model of Melanoma Reveals Differential Anti‐tumoral and Immunomodulatory Activities
von: Valentina Rigo, et al.
Veröffentlicht: (2025)

Mechanism of Musashi2 affecting radiosensitivity of lung cancer by modulating DNA damage repair
von: Hongjin Qu, et al.
Veröffentlicht: (2024)

Optimization and validation of a virus‐like particle pseudotyped virus neutralization assay for SARS‐CoV‐2
von: Shuo Liu, et al.
Veröffentlicht: (2024)

Current clinical findings of acute neurological syndromes after SARS‐CoV‐2 infection
von: Minjin Wang, et al.
Veröffentlicht: (2024)

Avelumab mediates antibody‐dependent cellular cytotoxicity against monocyte‐derived dendritic cells through natural killer cells
von: Tatjana Sauerer, et al.
Veröffentlicht: (2025)

Eupalinolide B inhibits periodontitis development by targeting ubiquitin conjugating enzyme UBE2D3
von: Wenhua Kuang, et al.
Veröffentlicht: (2025)

Dual Targeting of DNA and EGFR by ZYH005 Induces DNA Damage and Mitotic Catastrophe in Glioblastoma
von: Jianzheng Huang, et al.
Veröffentlicht: (2026)

Cellular senescence in cancer: molecular mechanisms and therapeutic targets
von: Ping Jin, et al.
Veröffentlicht: (2024)